GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | |
|---|---|---|---|
| Profit Before Tax | ₹87 Cr | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹65 Cr | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹-95 Cr | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹57 Cr | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹45 Cr | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-31 Cr | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹32 Cr | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹46 Cr | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹16 Cr | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹62 Cr | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹4,307.9 Cr | 3.3% | 1.6% | 34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 3.3% |
1.6% |
34% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses